Search Results Search Sort by RelevanceMost Recent Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78 Viewpoint Dec 2006 A Caution against Medical Student Tourism Mary Terrell White, PhD and Katherine L. Cauley, PhD Virtual Mentor. 2006;8(12):851-854. doi: 10.1001/virtualmentor.2006.8.12.oped1-0612. Viewpoint Dec 2006 Student Clinical Experiences in Africa: Who Are We Helping? Craig J. Conard, Mark J. Kahn, MD, Karen B. DeSalvo, MD, MPH, MSc, and L. Lee Hamm, MD Virtual Mentor. 2006;8(12):855-858. doi: 10.1001/virtualmentor.2006.8.12.oped2-0612. Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.
Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78
Viewpoint Dec 2006 A Caution against Medical Student Tourism Mary Terrell White, PhD and Katherine L. Cauley, PhD Virtual Mentor. 2006;8(12):851-854. doi: 10.1001/virtualmentor.2006.8.12.oped1-0612.
Viewpoint Dec 2006 Student Clinical Experiences in Africa: Who Are We Helping? Craig J. Conard, Mark J. Kahn, MD, Karen B. DeSalvo, MD, MPH, MSc, and L. Lee Hamm, MD Virtual Mentor. 2006;8(12):855-858. doi: 10.1001/virtualmentor.2006.8.12.oped2-0612.
Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.